Mankind Pharma Ltd

NSE: MANKIND · BSE: 543904 · Pharmaceuticals & Biotechnology · 50 announcements

Share price: ₹2,500.00
Market cap: ₹1,03,261 Cr
Revenue (annual): ₹14,278 Cr
Net profit (annual): ₹1,913 Cr
P/E (TTM): 50.5×Sector 47.4×
Promoter holding: 72.63%-0.03% QoQ
FII holding: 9.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 10 Employee Stock Options 6 Annual General Meeting 5 Other Announcement 4 Management Change 4 Earnings Call 4 Financial Results 3 Debt & Borrowing 3 Results Update 2 Credit Rating 2 Board Meeting Date 2 Share Pledge 1 Partnership 1 Business Update 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

30 Jul 2026 15:23 IST BSE

Financial ResultsAlfa Alert

Mankind Pharma Q1 FY27 Results: Net Profit ₹574.1 Cr, Up 29.1% YoY

Mankind Pharma Ltd reported revenue from operations of ₹4,031 Cr (+12.9% YoY) and net profit of ₹574.1 Cr (+29.1% YoY) for Q1 FY27.

Key figure: Net profit ₹574.1 Cr · +29.1% YoY

Open full results → Read the filing ↗

19 May 2026 19:14 IST NSE

Financial ResultsAlfa Alert

Mankind Pharma Q4 FY26 Results: Net Profit ₹559.4 Cr, Up 31.7% YoY

Mankind Pharma Ltd reported revenue from operations of ₹3,443 Cr (+11.8% YoY) and net profit of ₹559.4 Cr (+31.7% YoY) for Q4 FY26.

Key figure: Net profit ₹559.4 Cr · +31.7% YoY

Open full results → Read the filing ↗

19 May 2026 19:13 IST NSE

Financial Results

Mankind Pharma Financial Results

Mankind Pharma approved its audited FY26 results, reporting consolidated annual revenue of ₹14,277.64 Crore. The Board also cleared a ₹500 Crore investment in its Medicare subsidiary.

Read the filing ↗